Thursday, 8 February 2018

Regeneron profit beats on higher sales

(Reuters) - Regeneron Pharmaceuticals Inc's quarterly profit beat estimates on Thursday, helped by higher sales including flagship eye treatment Eylea.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)